Claudia Lengerke

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 27

Top Venues

Cancer research

Blood

Cancers

Communications biology

Eberhard-Karls-Universität Tübingen Medizinische Fakultät

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Eberhard-Karls-Universität Tübingen Medizinische Fakultät May 1o 2020

Germany

Professor and Medical Director :: Hematology, Oncology, Clinical Immunology and Rheumatology

Publications

Estelle Erkner, Thomas Hentrich, Rebekka Schairer, Rahel Fitzel, Kathy-Ann Secker-Grob, Johan Jeong, Hildegard Keppeler, Fulya Korkmaz, Julia M Schulze-Hentrich, Claudia Lengerke, Dominik Schneidawind, Corina Schneidawind
The RORɣ/SREBP2 pathway is a master regulator of cholesterol metabolism and serves as potential therapeutic target in t(4;11) leukemia. Oncogene (2023)
Philipp Schaible, Wolfgang Andreas Bethge, Claudia Lengerke, Reka Agnes Haraszti
RNA Therapeutics for Improving CAR T-cell Safety and Efficacy. Cancer research 83 (3) (2023)
Jacqueline Fischer, Estelle Erkner, Rahel Fitzel, Pia Radszuweit, Hildegard Keppeler, Fulya Korkmaz, Giovanni Roti, Claudia Lengerke, Dominik Schneidawind, Corina Schneidawind
Uncovering NOTCH1 as a Promising Target in the Treatment of MLL -Rearranged Leukemia. International journal of molecular sciences 24 (19) (2023)
Anja Schmitt, Melanie Grimm, Nina Kreienkamp, Hannah Junge, Jan Labisch, Laurentz Schuhknecht, Caroline Schönfeld, Elsa Sophie Görsch, Alessia Tibello, Kerstin Menck, Annalen Bleckmann, Claudia Lengerke, Frank Rosenbauer, Michael Grau, Mattia Zampieri, Klaus Schulze-Osthoff, Pavel Klener, Alexandra Dolnikova, Georg Lenz, Stephan Hailfinger
BRD4 inhibition sensitizes diffuse large B-cell lymphoma cells to ferroptosis. Blood (2023)
Sina A Beer, Stefan Wirths, Wichard Vogel, Ghazaleh Tabatabai, Ulrike Ernemann, David A Merle, Wolfgang Andreas Bethge, Robert Möhle, Claudia Lengerke
Patient Reported and Clinical Outcomes after High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Primary Central Nervous System Lymphoma. Cancers 15 (3) (2023)
Philipp Schaible, Wolfgang Andreas Bethge, Claudia Lengerke, Reka Agnes Haraszti
RNA Therapeutics for Improving CAR T-cell Safety and Efficacy. Cancer research 83 (3) (2023)
Philipp Schaible, Wolfgang Andreas Bethge, Claudia Lengerke, Reka Agnes Haraszti
RNA Therapeutics for Improving CAR T-cell Safety and Efficacy. Cancer research 83 (3) (2023)
Sina A Beer, Stefan Wirths, Wichard Vogel, Ghazaleh Tabatabai, Ulrike Ernemann, David A Merle, Wolfgang Andreas Bethge, Robert Möhle, Claudia Lengerke
Patient Reported and Clinical Outcomes after High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Primary Central Nervous System Lymphoma. Cancers 15 (3) (2023)
Annika Nelde, Heiko Schuster, Jonas S Heitmann, Jens Bauer, Yacine Maringer, Melissa Zwick, Jens-Peter Volkmer, James Y Chen, Anna M Paczulla Stanger, Ariane Lehmann, Bismark Appiah, Melanie Märklin, Elke Rücker-Braun, Helmut R Salih, Malte Roerden, Sarah M Schroeder, Max-Felix Häring, Andreas Schlosser, Johannes Schetelig, Marc Schmitz, Melanie Boerries, Natalie Stickel, Claudia Lengerke, Ravindra Majeti, Irving L Weissman, Hans-Georg Rammensee, Juliane Sarah Walz
Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells. Blood cancer discovery (2023)
Philipp Schaible, Wolfgang Andreas Bethge, Claudia Lengerke, Reka Agnes Haraszti
RNA Therapeutics for Improving CAR T-cell Safety and Efficacy. Cancer research 83 (3) (2023)
Wolfgang Andreas Bethge, Peter Martus, Michael Schmitt, Udo Holtick, Marion Subklewe, Bastian von Tresckow, Francis Ayuk, Eva Maria Wagner-Drouet, Gerald G Wulf, Reinhard Marks, Olaf Penack, Ulf Schnetzke, Christian Koenecke, Malte von Bonin, Matthias Stelljes, Bertram Glass, Claudia D Baldus, Vladan Vucinic, Dimitrios Mougiakakos, Max Topp, Matthias A Fante, Roland Schroers, Lale Bayir, Peter Borchmann, Veit L Bücklein, Justin Hasenkamp, Christine Hanoun, Simone Thomas, Dietrich W Beelen, Claudia Lengerke, Nicolaus Kroeger, Peter Dreger
GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in Germany. Blood 140 (4) (2022)
Gaia Bianco, Mairene Coto-Llerena, John Gallon, Venkatesh Kancherla, Stephanie Taha-Mehlitz, Mattia Marinucci, Martina Konantz, Sumana Srivatsa, Hesam Montazeri, Federica Panebianco, Vijaya G Tirunagaru, Marta De Menna, Viola Paradiso, Caner Ercan, Ahmed Dahmani, Elodie Montaudon, Niko Beerenwinkel, Marianna Kruithof de Julio, Luigi M Terracciano, Claudia Lengerke, Rinath M Jeselsohn, Robert C Doebele, Francois-Clement Bidard, Elisabetta Marangoni, Charlotte C K Ng, Salvatore Piscuoglio
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers. Communications biology 5 (1) (2022)
Christian Philipp Reinert, Regine Mariette Perl, Christoph Faul, Claudia Lengerke, Konstantin Nikolaou, Helmut Dittmann, Wolfgang A Bethge, Marius Horger
Value of CT-Textural Features and Volume-Based PET Parameters in Comparison to Serologic Markers for Response Prediction in Patients with Diffuse Large B-Cell Lymphoma Undergoing CD19-CAR-T Cell Therapy. Journal of clinical medicine 11 (6) (2022)
Philipp Schaible, Wolfgang Andreas Bethge, Claudia Lengerke, Reka Agnes Haraszti
RNA therapeutics for improving CAR T cell safety and efficacy. Cancer research (2022)
Gaia Bianco, Mairene Coto-Llerena, John Gallon, Venkatesh Kancherla, Stephanie Taha-Mehlitz, Mattia Marinucci, Martina Konantz, Sumana Srivatsa, Hesam Montazeri, Federica Panebianco, Vijaya G Tirunagaru, Marta De Menna, Viola Paradiso, Caner Ercan, Ahmed Dahmani, Elodie Montaudon, Niko Beerenwinkel, Marianna Kruithof de Julio, Luigi M Terracciano, Claudia Lengerke, Rinath M Jeselsohn, Robert C Doebele, Francois-Clement Bidard, Elisabetta Marangoni, Charlotte C K Ng, Salvatore Piscuoglio
Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers. Communications biology 5 (1) (2022)
Anna Maria Paczulla Stanger, Claudia Lengerke
VCAM1 as a don't-eat-me molecule. Nature cell biology 24 (3) (2022)
Anja Schmitt, Wendan Xu, Philip Bucher, Melanie Grimm, Martina Konantz, Heike Horn, Myroslav Zapukhlyak, Philipp Berning, Marc Brändle, Mohamed-Ali Jarboui, Caroline Schönfeld, Karsten Boldt, Andreas Rosenwald, German Ott, Michael Grau, Pavel Klener, Petra Vockova, Claudia Lengerke, Georg Lenz, Klaus Schulze-Osthoff, Stephan Hailfinger
Dimethyl fumarate induces ferroptosis and impairs NF-κB/STAT3 signaling in DLBCL. Blood 138 (10) (2021)
Weijia Wang, Yang Zhang, Philip Dettinger, Andreas Reimann, Tobias Kull, Dirk Loeffler, Markus G Manz, Claudia Lengerke, Timm Schroeder
Cytokine combinations for human blood stem cell expansion induce cell-type- and cytokine-specific signaling dynamics. Blood 138 (10) (2021)
Dirk Loeffler, Florin Schneiter, Weijia Wang, Arne Wehling, Tobias Kull, Claudia Lengerke, Markus G Manz, Timm Schroeder
Asymmetric organelle inheritance predicts human blood stem cell fate. Blood (2021)
Shaima'a Hamarsheh, Lena Osswald, Benedikt S Saller, Susanne Unger, Donatella De Feo, Janaki Manoja Vinnakota, Martina Konantz, Franziska M Uhl, Heiko Becker, Michael Lübbert, Khalid Shoumariyeh, Christoph Schürch, Geoffroy Andrieux, Nils Venhoff, Annette Schmitt-Graeff, Sandra Duquesne, Dietmar Pfeifer, Matthew A Cooper, Claudia Lengerke, Melanie Boerries, Justus Duyster, Charlotte M Niemeyer, Miriam Erlacher, Bruce R Blazar, Burkhard Becher, Olaf Groß, Tilman Brummer, Robert Zeiser
Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation. Nature communications 11 (1) (2020)
Stefanie Kreutmair, Cathrin Klingeberg, Teresa Poggio, Geoffroy Andrieux, Alexander Keller, Christoph Cornelius Miething, Marie Follo, Dietmar Pfeifer, Khalid Shoumariyeh, Claudia Lengerke, Irene Gonzalez-Menendez, Falko Fend, Robert Zeiser, Suzanne D Turner, Leticia Quintanilla-Martinez, Melanie Boerries, Justus Duyster, Anna L Illert
Existence of reprogrammed lymphoma stem cells in a murine ALCL-like model. Leukemia 34 (12) (2020)
Marlon Arnone, Martina Konantz, Pauline Hanns, Anna M Paczulla Stanger, Sarah Bertels, Parimala Sonika Godavarthy, Maximilian Christopeit, Claudia Lengerke
Acute Myeloid Leukemia Stem Cells: The Challenges of Phenotypic Heterogeneity. Cancers 12 (12) (2020)
Thorsten Schaefer, Claudia Lengerke
SOX2 protein biochemistry in stemness, reprogramming, and cancer: the PI3K/AKT/SOX2 axis and beyond. Oncogene 39 (2) (2019)
Martina Konantz, Christoph Schürch, Pauline Hanns, Joëlle S Müller, Loïc Sauteur, Claudia Lengerke
Modeling hematopoietic disorders in zebrafish. Disease models & mechanisms 12 (9) (2019)
Sarah Kraft, Noémie Bollinger, Benjamin Bodenmann, Dominik Heim, Christoph Bucher, Claudia Lengerke, Martina Kleber, Dimitrios A Tsakiris, Jakob Passweg, Alexandar Tzankov, Michael Medinger
High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease. Bone marrow transplantation 54 (4) (2018)
Nimitha R Mathew, Francis Baumgartner, Lukas Braun, David O'Sullivan, Simone Thomas, Miguel Waterhouse, Tony A Müller, Kathrin Hanke, Sanaz Taromi, Petya Apostolova, Anna L Illert, Wolfgang Melchinger, Sandra Duquesne, Annette Schmitt-Graeff, Lena Osswald, Kai-Li Yan, Arnim Weber, Sonia Tugues, Sabine Spath, Dietmar Pfeifer, Marie Follo, Rainer Claus, Michael Lübbert, Christoph Rummelt, Hartmut Bertz, Ralph Wäsch, Johanna Haag, Andrea Schmidts, Michael Schultheiss, Dominik Bettinger, Robert Thimme, Evelyn Ullrich, Yakup Tanriver, Giang Lam Vuong, Renate Arnold, Philipp Hemmati, Dominik Wolf, Markus Ditschkowski, Cordula Jilg, Konrad Wilhelm, Christian Leiber, Sabine Gerull, Jörg Halter, Claudia Lengerke, Thomas Pabst, Thomas Schroeder, Guido Kobbe, Wolf Rösler, Soroush Doostkam, Stephan Meckel, Kathleen Stabla, Stephan K Metzelder, Sebastian Halbach, Tilman Brummer, Zehan Hu, Joern Dengjel, Björn Hackanson, Christoph Schmid, Udo Holtick, Christof Scheid, Alexandros Spirydonidis, Friedrich Stölzel, Rainer Ordemann, Lutz P Müller, Flore Sicre-de-Fontbrune, Gabriele Ihorst, Jürgen Kuball, Jan E Ehlert, Daniel Feger, Eva-Maria Wagner, Jean-Yves Cahn, Jacqueline Schnell, Florian Kuchenbauer, Donald Bunjes, Ronjon Chakraverty, Simon Richardson, Saar Gill, Nicolaus Kröger, Francis Ayuk, Luca Vago, Fabio Ciceri, Antonia M Müller, Takeshi Kondo, Takanori Teshima, Susan Klaeger, Bernhard Kuster, Dennis Dong Hwan Kim, Daniel Weisdorf, Walter van der Velden, Daniela Dörfel, Wolfgang Bethge, Inken Hilgendorf, Andreas Hochhaus, Geoffroy Andrieux, Melanie Börries, Hauke Busch, John Magenau, Pavan Reddy, Myriam Labopin, Joseph H Antin, Andrea S Henden, Geoffrey R Hill, Glen A Kennedy, Merav Bar, Anita Sarma, Donal McLornan, Ghulam Mufti, Betul Oran, Katayoun Rezvani, Omid Shah, Robert S Negrin, Arnon Nagler, Marco Prinz, Andreas Burchert, Andreas Neubauer, Dietrich Beelen, Andreas Mackensen, Nikolas von Bubnoff, Wolfgang Herr, Burkhard Becher, Gerard Socié, Michael A Caligiuri, Eliana Ruggiero, Chiara Bonini, Georg Häcker, Justus Duyster, Jürgen Finke, Erika Pearce, Bruce R Blazar, Robert Zeiser
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells. Nature medicine 24 (3) (2018)
Martina Konantz, Elisa Alghisi, Joëlle S Müller, Anna Lenard, Virginie Esain, Kelli J Carroll, Lothar Kanz, Trista E North, Claudia Lengerke
Evi1 regulates Notch activation to induce zebrafish hematopoietic stem cell emergence. The EMBO journal 35 (21) (2016)

Claudia Lengerke.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Claudia Lengerke